| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |